ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 72 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $13,233,000 | -64.1% | 701,662 | -77.6% | 0.01% | -64.7% |
| Q2 2019 | $36,844,000 | -13.6% | 3,130,287 | +0.2% | 0.02% | -19.0% |
| Q1 2019 | $42,624,000 | +66.7% | 3,122,597 | +25.2% | 0.02% | +50.0% |
| Q4 2018 | $25,563,000 | -38.1% | 2,493,975 | +0.6% | 0.01% | -22.2% |
| Q3 2018 | $41,280,000 | +42.5% | 2,479,322 | +35.2% | 0.02% | +28.6% |
| Q2 2018 | $28,975,000 | +662.3% | 1,833,885 | +512.7% | 0.01% | +600.0% |
| Q1 2018 | $3,801,000 | -86.2% | 299,289 | -87.6% | 0.00% | -88.2% |
| Q4 2017 | $27,556,000 | +20.6% | 2,406,641 | +29.1% | 0.02% | 0.0% |
| Q3 2017 | $22,841,000 | +168.1% | 1,864,654 | +150.6% | 0.02% | +142.9% |
| Q2 2017 | $8,520,000 | -12.4% | 744,188 | +59.2% | 0.01% | -22.2% |
| Q1 2017 | $9,722,000 | +1210.2% | 467,387 | +1209.4% | 0.01% | +800.0% |
| Q4 2016 | $742,000 | -97.3% | 35,696 | -95.8% | 0.00% | -96.6% |
| Q3 2016 | $27,918,000 | +1267.2% | 851,924 | +941.8% | 0.03% | +1350.0% |
| Q2 2016 | $2,042,000 | -76.7% | 81,771 | -77.2% | 0.00% | -81.8% |
| Q1 2016 | $8,777,000 | -19.0% | 358,376 | +9.3% | 0.01% | -8.3% |
| Q4 2015 | $10,830,000 | -33.1% | 327,887 | -33.7% | 0.01% | -20.0% |
| Q3 2015 | $16,193,000 | -46.6% | 494,295 | -13.7% | 0.02% | -42.3% |
| Q2 2015 | $30,328,000 | +39.3% | 572,552 | -24.1% | 0.03% | +23.8% |
| Q1 2015 | $21,773,000 | +78.5% | 754,464 | +80.0% | 0.02% | +75.0% |
| Q4 2014 | $12,195,000 | +5133.9% | 419,253 | +2189.7% | 0.01% | – |
| Q3 2014 | $233,000 | – | 18,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |